Peer-reviewedCC BYCancer biology & therapy
Statement of Retraction: Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Related
- Long-Noncoding RNA PCAT6 Aggravates Osteosarcoma Tumourigenesis via the MiR-143-3p/ZEB1 Axis [Retraction].
- Statement of Retraction: Fischer's oligopeptide ratio in ischemic hypoxia: prophylactic amendment of sophoretin and melatonin supplementation.
- Statement of Retraction: Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/reperfusion injury via inhibiting JAK/STAT pathway.
- DUSP13 promotes prostate cancer progression by regulating the ERK1/2 pathway
- URGCP promotes osteosarcoma progression by regulating the ESCRT-III subunit CHMP4B
BibTeX
@article{anon2026statement,
title = {{Statement of Retraction: Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.}},
journal = {Cancer biology \& therapy},
year = {2026},
month = oct,
doi = {10.1080/15384047.2026.2746185},
url = {https://europepmc.org/article/MED/42850778},
note = {CC BY},
}
RIS
TY - JOUR
TI - Statement of Retraction: Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
PY - 2026
DA - 2026/10/08
JO - Cancer biology & therapy
DO - 10.1080/15384047.2026.2746185
UR - https://europepmc.org/article/MED/42850778
SN - 1538-4047
SN - 1555-8576
ER -